Dimethyl Fumarate protects pancreatic islet cells and non-endocrine tissue in L-Arginine-induced chronic pancreatitis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Robles, Lourdes ^a   Vaziri, Nosratola D ^a   Li, Shiri ^a   Masuda, Yuichi ^a   Takasu, Chie ^a   Takasu, Mizuki ^a   Vo, Kelly ^a   Farzaneh, Seyed H ^a   Stamos, Michael J ^a   Ichii, Hirohito ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FUMARIC ACID DIMETHYL ESTER; HEME OXYGENASE 1; MYELOPEROXIDASE; IMMUNOSUPPRESSIVE AGENT; PROTECTIVE AGENT;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DAMAGE; CELL DEATH; CELL INFILTRATION; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CHRONIC PANCREATITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; EDEMA; ENZYME BLOOD LEVEL; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; HISTOLOGY; IN VITRO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ATROPHY; PANCREAS DISEASE; PANCREAS ISLET CELL; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EXOCRINE PANCREAS; HUMAN; METABOLISM; PANCREAS ISLET; PANCREATITIS, CHRONIC; PATHOLOGY; WISTAR RAT;

ANIMALS; ARGININE; DIMETHYL FUMARATE; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; MALE; PANCREAS, EXOCRINE; PANCREATITIS, CHRONIC; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84910660431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107111     Document Type: Article

References (32)

1. Braganza JM, Lee SH, McCloy RF, McMahon MJ (2011) Chronic pancreatitis. Lancet 377: 1184-1197.
2. Chen JM, Ferec C (2012) Genetics and pathogenesis of chronic pancreatitis: the 2012 update. Clin Res Hepatol Gastroenterol 36: 334-340.
3. Jupp J, Fine D, Johnson CD (2010) The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol 24: 219-231.
4. Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, et al. (2005) Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 100: 918-926.
5. McEntee GP, Gillen P, Peel AL (1987) Alcohol induced pancreatitis: social and surgical aspects. Br J Surg 74: 402-404.
6. Ashrafian H, Czibik G, Bellahcene M, Aksentijevic D, Smith AC, et al. (2012) Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 15: 361-371.
7. Ghoreschi K, Bruck J, Kellerer C, Deng C, Peng H, et al. (2011) Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 208: 2291-2303.
8. Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, et al. (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134: 678-692.
9. Meili-Butz S, Niermann T, Fasler-Kan E, Barbosa V, Butz N, et al. (2008) Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats. Eur J Pharmacol 586: 251-258.
10. Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, et al. (2004) Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/ reperfusion injury. Cardiovasc Res 63: 51-59.
11. Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, et al. (2012) Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 341: 274-284.
12. Oh CJ, Kim JY, Choi YK, Kim HJ, Jeong JY, et al. (2012) Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling. Plos One 7: e45870.
13. Yamaguchi T, Kihara Y, Taguchi M, Nagashio Y, Tashiro M, et al. (2005) Persistent destruction of the basement membrane of the pancreatic duct contributes to progressive acinar atrophy in rats with experimentally induced pancreatitis. Pancreas 31: 365-372.
14. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, et al. (1992) A better model of acute pancreatitis for evaluating therapy. Ann Surg 215: 44-56.
15. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438.
16. Shapiro AM, Hao E, Rajotte RV, Kneteman NM (1996) High yield of rodent islets with intraductal collagenase and stationary digestion-a comparison with standard technique. Cell Transplant 5: 631-638.
17. Ricordi C (1995) Methods in Cell Transplantation; Ricordi C, editor: R G Landes Co.
18. Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, et al. (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27: 185-195.
19. Ichii H, Inverardi L, Pileggi A, Molano RD, Cabrera O, et al. (2005) A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 5: 1635-1645.
20. Takacs T, Czako L, Morschl E, Laszlo F, Tiszlavicz L, et al. (2002) The role of nitric oxide in edema formation in L-arginine-induced acute pancreatitis. Pancreas 25: 277-282.
21. Lau HYB, Madhav (2012) Quantitating inflammation in a mouse model of acute pancreatitis. The Pancreapedia: Exocrine Pancreas Knowledge Base.
22. Weaver C, Bishop AE, Polak JM (1994) Pancreatic changes elicited by chronic administration of excess L-arginine. Exp Mol Pathol 60: 71-87.
23. Kostromina E, Gustavsson N, Wang X, Lim CY, Radda GK, et al. (2010) Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas. Endocrinology 151: 2050-2059.
24. Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20: 463-466.
25. Mrowietz U, Asadullah K (2005) Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med 11: 43-48.
26. Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, et al. (2001) The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 144: 1114-1120.
27. Seidel C, Bicker G (2002) Developmental expression of nitric oxide/cyclic GMP signaling pathways in the brain of the embryonic grasshopper. Brain Res Dev Brain Res 138: 71-79.
28. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, et al. (2012) Placebocontrolled phase 3 study of oral BG-12 for relapsing multiple sclerosis. The New England journal of medicine 367: 1098-1107.
29. Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, et al. (2007) Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 127: 835-845.
30. Kikuchi G, Yoshida T, Noguchi M (2005) Heme oxygenase and heme degradation. Biochem Biophys Res Commun 338: 558-567.
31. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, et al. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86.
32. Li ZD, Ma QY, Wang CA (2006) Effect of resveratrol on pancreatic oxygen free radicals in rats with severe acute pancreatitis. World J Gastroenterol 12: 137-140.